首页> 外文OA文献 >Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

【2h】

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

机译：舒法他嗪和美沙拉嗪：根据向药物安全委员会报告的可疑不良反应报告，对严重不良反应进行了重新评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background: 5-Aminosalicylates are extensively prescribed for the treatment of ulcerative colitis but have a wide range of described adverse effects.

机译：背景：5-氨基水杨酸盐广泛用于治疗溃疡性结肠炎，但具有广泛的不良反应。

著录项

作者
Ransford, R A J; Langman, M J S;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Suspected adverse reactions after vaccination. Results from the German Health Interview and Examination Survey for Children and Adolescents. Part 2: predictors of parental reporting of suspected adverse reactions after vaccinations [J] . Poethko Muller C, Atzpodien K, Schmitz R, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz . 2011,第3期

机译：接种后怀疑有不良反应。德国儿童和青少年健康访问与检查调查的结果。第2部分：疫苗接种后家长报告可疑不良反应的预测因素
2. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review [J] . Schussler Edith, Sobel Jeremy, Hsu Joy, Clinical infectious diseases . 2018,第Suppla1期

机译：涉及美国过敏院，哮喘和免疫学（AAAAI）的联合工作组的工作组报告; 食物过敏，过敏反应，皮肤病学和药物过敏（Fadda）（对食品委员会的不良反应以及对药物，生物和乳胶委员会的不良反应）; 和疾病控制和预防肉类主义的中心临床治疗指南工程群 - 肉毒杆菌抗毒素的过敏反应：系统审查
3. Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions. [J] . Aronson JK Drug safety: An international journal of medical toxicology and drug experience . 2008,第4期

机译：轶事地发布药物不良反应的历史记录：PHARMA指南用于报告可疑的药物不良反应。
4. A High Performance Agent-Based System for Reporting Suspected Adverse Drug Reactions [C] . Ji Yanqing, Shen Fangyang, Tran John Information Technology: New Generations (ITNG), 2012 Ninth International Conference on . 2012

机译：基于高性能代理的可疑药物不良反应报告系统
5. Signal Detection of Adverse Drug Reaction using the Adverse Event Reporting System: Literature Review and Novel Methods [D] . Pham, Minh H. 2018

机译：使用不良事件报告系统的不良药物反应的信号检测：文献综述和新方法
6. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines [O] . R F Logan, T P van Staa, M J S Langman, 2003

机译：舒法他嗪和美沙拉嗪：根据向药品安全委员会报告的可疑不良反应报告对严重不良反应进行了重新评估
7. Suspected adverse drug reactions in elderly patients reported to the Committee on Safety of Medicines. [O] . Castleden, C M, Pickles, H 1988

机译：向药品安全委员会报告了老年患者的疑似药物不良反应。

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅